BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirón-rubio M, González-ramallo V, Estrada-cuxart O, Sanroma-mendizábal P, Segado-soriano A, Mujal-martínez A, Del Río-vizoso M, García-lezcano M, Martín-blanco N, Florit-serra L, Gil-bermejo M. Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry. Future Microbiology 2016;11:375-90. [DOI: 10.2217/fmb.15.141] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Pajarón-Guerrero M, Fernández-Miera MF, Dueñas-Puebla JC, Cagigas-Fernández C, Allende-Mancisidor I, Cristóbal-Poch L, Gómez-Fleitas M, Manzano-Peral MA, Gonzalez-Fernandez CR, Aguilera-Zubizarreta A, Sanroma-Mendizábal P; Hospital Valdecilla ERAS Study Group. Early Discharge Programme on Hospital-at-Home Evaluation for Patients with Immediate Postoperative Course after Laparoscopic Colorectal Surgery. Eur Surg Res 2017;58:263-73. [PMID: 28793287 DOI: 10.1159/000479004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Wee LE, Sundarajoo M, Quah WF, Farhati A, Huang JY, Chua YY. Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017. Eur J Clin Microbiol Infect Dis 2019;38:277-84. [PMID: 30430375 DOI: 10.1007/s10096-018-3424-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ingram PR, Ng J, Mathieson C, Mowlaboccus S, Coombs G, Raby E, Dyer J. A clinical and in vitro assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infections. JAC Antimicrob Resist 2021;3:dlab128. [PMID: 34377984 DOI: 10.1093/jacamr/dlab128] [Reference Citation Analysis]
4 Sriskandarajah S, Hobbs J, Roughead E, Ryan M, Reynolds K. Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies. Int J Clin Pract 2018;:e13216. [PMID: 29920884 DOI: 10.1111/ijcp.13216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
5 González-Ramallo VJ, Mirón-Rubio M, Mujal A, Estrada O, Forné C, Aragón B, Rivera AJ. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain. Int J Antimicrob Agents 2017;50:114-8. [PMID: 28499957 DOI: 10.1016/j.ijantimicag.2017.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
6 Gil-Navarro MV, Lopez-Cortes LE, Luque-Marquez R, Galvez-Acebal J, de Alarcon-Gonzalez A. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis. J Clin Pharm Ther 2018;43:220-3. [PMID: 29030859 DOI: 10.1111/jcpt.12635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Sanroma P, Muñoz P, Mirón-Rubio M, Aguilera A, Estrada O, García D, González-Ramallo VJ, Pajarón M, Sgaramella GA, González CR, Mujal A, Abad A, Solé A, González S, Escalada C, Vitoria I, Gómez MJ, Parra JJ, Sampedro I, Pereda I. Effectiveness and safety of ertapenem used in hospital-at-home units: data from Spanish Outpatient Parenteral Antimicrobial Therapy Registry. Future Microbiol 2018;13:1363-73. [PMID: 30238769 DOI: 10.2217/fmb-2018-0065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Webster J, Northfield S, Larsen EN, Marsh N, Rickard CM, Chan RJ. Insertion site assessment of peripherally inserted central catheters: Inter-observer agreement between nurses and inpatients. J Vasc Access 2018;19:370-4. [PMID: 29560795 DOI: 10.1177/1129729818757965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Tan SJ, Ingram PR, Rothnie AJ, Whitmore TJ, Robinson JO, Hatch JB, Italiano CM, Heath CH. Successful outpatient parenteral antibiotic therapy delivery via telemedicine. J Antimicrob Chemother 2017;72:2898-901. [PMID: 29091189 DOI: 10.1093/jac/dkx203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
10 Ponce González MA, Mirón Rubio M, Mujal Martinez A, Estrada Cuxart O, Fiuza Perez D, Salas Reinoso L, Fernández Fabrellas E, Chiner Vives E. Effectiveness and safety of outpatient parenteral antimicrobial therapy in acute exacerbation of chronic obstructive pulmonary disease. Int J Clin Pract 2017;71. [PMID: 28949430 DOI: 10.1111/ijcp.13022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hiew J, Whitmore T, McEvoy M, Weatherall D, Ingram PR, Manning L. Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy study. Intern Med J 2021;51:1717-21. [PMID: 34664365 DOI: 10.1111/imj.15511] [Reference Citation Analysis]
12 García-Queiruga M, Feal Cortizas B, Lamelo Alfonsín F, Pertega Diaz S, Martín-Herranz I. Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting. Rev Esp Quimioter 2021;34:200-6. [PMID: 33724755 DOI: 10.37201/req/122.2020] [Reference Citation Analysis]
13 Torres-Del-Pliego E, Delgado-Mejía E, Gil-Alonso L, Del Mar-Periáñez-Párraga L. First case of ceftazidime/avibactam administration in home care. ESBL producing Klebsiella pneumoniae bacteremia. Enferm Infecc Microbiol Clin 2017;35:322-3. [PMID: 27712848 DOI: 10.1016/j.eimc.2016.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Chapman ALN, Patel S, Horner C, Green H, Guleri A, Hedderwick S, Snape S, Statham J, Wilson E, Gilchrist M, Seaton RA. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC Antimicrob Resist 2019;1:dlz026. [PMID: 34222901 DOI: 10.1093/jacamr/dlz026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
15 Gil-Navarro MV, Luque-Marquez R, Báez-Gutiérrez N, Álvarez-Marín R, Navarro-Amuedo MªD, Praena-Segovia J, Carmona-Caballero JM, Fraile-Ramos E, López-Cortés LE. Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients. Enferm Infecc Microbiol Clin (Engl Ed) 2020;38:479-84. [PMID: 32143891 DOI: 10.1016/j.eimc.2020.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]